LU81440A1 - Octahydro-2h-pyrrolo(3,4-g)quinoleines et leur utilisation therapeutique - Google Patents

Octahydro-2h-pyrrolo(3,4-g)quinoleines et leur utilisation therapeutique

Info

Publication number
LU81440A1
LU81440A1 LU81440A LU81440A LU81440A1 LU 81440 A1 LU81440 A1 LU 81440A1 LU 81440 A LU81440 A LU 81440A LU 81440 A LU81440 A LU 81440A LU 81440 A1 LU81440 A1 LU 81440A1
Authority
LU
Luxembourg
Prior art keywords
quinoleines
octahydro
pyrrolo
therapeutic use
therapeutic
Prior art date
Application number
LU81440A
Other languages
English (en)
French (fr)
Inventor
N Bach
E Kornfeld
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/031,642 external-priority patent/US4235909A/en
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of LU81440A1 publication Critical patent/LU81440A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/22—Oxygen atoms attached in position 2 or 4
    • C07D215/227—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
LU81440A 1979-01-22 1979-06-27 Octahydro-2h-pyrrolo(3,4-g)quinoleines et leur utilisation therapeutique LU81440A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US506279A 1979-01-22 1979-01-22
US06/031,642 US4235909A (en) 1979-04-19 1979-04-19 Octahydro-2H-pyrrolo[3,4-g]quinolines

Publications (1)

Publication Number Publication Date
LU81440A1 true LU81440A1 (fr) 1979-09-12

Family

ID=26673871

Family Applications (1)

Application Number Title Priority Date Filing Date
LU81440A LU81440A1 (fr) 1979-01-22 1979-06-27 Octahydro-2h-pyrrolo(3,4-g)quinoleines et leur utilisation therapeutique

Country Status (25)

Country Link
EP (1) EP0013788B1 (ja)
JP (1) JPS55100385A (ja)
AR (1) AR225012A1 (ja)
AT (1) AT365189B (ja)
AU (1) AU528035B2 (ja)
BE (1) BE877328A (ja)
CA (1) CA1131227A (ja)
CH (2) CH641801A5 (ja)
DD (1) DD144668A5 (ja)
DE (1) DE2965277D1 (ja)
DK (1) DK268979A (ja)
ES (1) ES482084A1 (ja)
FI (1) FI65248C (ja)
FR (2) FR2446833A1 (ja)
GB (1) GB2040917B (ja)
IE (1) IE48295B1 (ja)
IL (1) IL57665A (ja)
LU (1) LU81440A1 (ja)
NZ (1) NZ190834A (ja)
PH (2) PH15118A (ja)
PL (1) PL125785B1 (ja)
PT (1) PT69828A (ja)
RO (1) RO77442A (ja)
SU (1) SU1113006A3 (ja)
ZA (1) ZA793244B (ja)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL65269A0 (en) * 1981-03-24 1982-05-31 Lilly Co Eli 6-substituted hexahydroindazolo or hexahydroisoindolo isoquinolines
DE3373468D1 (de) * 1983-06-03 1987-10-15 Lilly Co Eli Trans-dl-1-alkyl-6-alkoxyoctahydroquinolines
IL73001A0 (en) * 1983-09-26 1984-12-31 Lilly Co Eli Improvements in and relating to 6-oxodecahydroquinolines
US4595754A (en) * 1985-03-04 1986-06-17 Eli Lilly And Company Process for preparing cis N-alkylperhydroquinolines
AR067027A1 (es) * 2007-06-19 2009-09-30 Astrazeneca Ab Derivados de 2, 3-dihidro-1h-pirrol[3, 4b]quinolin-1-ona, una composicion farmaceutica que los comprende y su uso en la fabricacion de un medicamento para el tratamiento de enfermedades mediadas por la modulacion de la actividad del receptor gaba a.
TWI537274B (zh) 2011-03-14 2016-06-11 橘生藥品工業股份有限公司 新穎之八氫噻吩并喹啉衍生物、含有其之醫藥組成物及該等之用途

Also Published As

Publication number Publication date
ATA452579A (de) 1981-05-15
EP0013788A1 (en) 1980-08-06
DE2965277D1 (en) 1983-06-01
PH16181A (en) 1983-07-25
PH15118A (en) 1982-08-10
ES482084A1 (es) 1980-08-01
JPS55100385A (en) 1980-07-31
BE877328A (fr) 1979-12-28
FI65248B (fi) 1983-12-30
AR225012A1 (es) 1982-02-15
GB2040917B (en) 1983-01-06
IE48295B1 (en) 1984-11-28
PT69828A (en) 1979-07-01
FR2446835A1 (fr) 1980-08-14
EP0013788B1 (en) 1983-04-27
DK268979A (da) 1980-07-23
PL125785B1 (en) 1983-06-30
PL216721A1 (ja) 1980-06-16
IL57665A0 (en) 1979-10-31
IL57665A (en) 1982-11-30
CH643258A5 (fr) 1984-05-30
FR2446833B1 (ja) 1982-03-05
AU528035B2 (en) 1983-04-14
JPS6233233B2 (ja) 1987-07-20
FR2446835B1 (ja) 1982-04-23
GB2040917A (en) 1980-09-03
AU4844479A (en) 1980-07-31
FI792047A (fi) 1980-07-23
ZA793244B (en) 1981-02-25
NZ190834A (en) 1984-07-06
RO77442A (ro) 1982-10-26
DD144668A5 (de) 1980-10-29
FI65248C (fi) 1984-04-10
SU1113006A3 (ru) 1984-09-07
CA1131227A (en) 1982-09-07
FR2446833A1 (fr) 1980-08-14
CH641801A5 (fr) 1984-03-15
IE791210L (en) 1980-10-19
AT365189B (de) 1981-12-28

Similar Documents

Publication Publication Date Title
LU81439A1 (fr) Octahydro-pyrazolo(3,4-g)quinoleines et leur utilisation therapeutique
BE873883A (fr) 6-n-propyl-8-methoxymethyl ou methylmercaptomethylergolines et composes apparentes, et leur utilisation therapeutique
BE884300A (fr) Amides, leur preparation et leur utilisation
LU81458A1 (fr) Phenethanolamines et leur utilisation therapeutique
LU80922A1 (fr) 9-amino-et imino-dibenzopyrannes et leur utilisation therapeutique
BE882601A (fr) Mercaptoacyldipeptides, leur preparation et leur utilisation
BE869509A (fr) Pyrazoles substitues en position 4, leur preparation et leur utilisation therapeutique
BE880220A (fr) 1,2,4,5-tetra-alkyl-4-arylpiperidines, leur utilisation therapeutique, leur preparation et les intermediaires appropries
BE882166A (fr) 9-aminoalkylfluorenes, leur preparation et leur utilisation therapeutique
BE872134A (fr) Nouvelles indolo (2,3,a) quinolizidines, leur preparation et leur utilisation therapeutique
BE885117A (fr) 3-amino-oxazolidin-2-ones, leur preparation et leur utilisation
BE882010A (fr) Tetrahydrobenzothiazolylimidazolidinones et leur utilisation
LU80719A1 (fr) Trans-4a-aryl-octahydro-1h-2-pyrindines et leur utilisation therapeutique
BE877328A (fr) Octahydro-2h-pyrrolo (3,4-g) quinoleines et leur utilisation therapeutique
BE866728A (fr) 1,2,4-triazoles, leur preparation et leur utilisation
BE891585A (fr) 5 alpha-androstane-17 beta-carboxylates et 5 beta-androstane-17 beta-carboxylates, leur preparation et leur utilisation
LU81437A1 (fr) 2-azaergolines et 2-aza-8(ou 9)ergolenes et leur utilisation therapeutique
BE874430A (fr) 2,3-dihydroimidazo (1,2,c) pyrimidines substituees et leur utilisation therapeutique
BE884990A (fr) Thiadiazine-amines, leur preparation et leur utilisation
BE882167A (fr) (1,1-biphenyl-2-yl)-propyl- et butylamines, leur preparation et leur utilisation therapeutique
BE876680A (fr) Arylalkyl- et aryloxyalkyl- phosphonates, leur preparation et leur utilisation therapeutique
BE871724A (fr) 4-desacetoxy-4 alpha-hydroxyindole-dihydroindoles et leur utilisation therapeutique
LU80161A1 (fr) 2,1-benzisothiazoles,leur preparation et leur utilisation therapeutique
BE874662A (fr) Benzocycloheptapyrannes et leur utilisation therapeutique
BE880288A (fr) Hexahydro-2,6-methano-3-benzazocines, leur preparation et leur utilisation therapeutique